# Study of Safety and Immunogenicity of Fluzone® in Healthy Children

> **NCT00831675** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 30 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza Vaccine 2004-2005 Paediatric Formulation
- **BIOLOGICAL:** Influenza Vaccine 2004-2005 Paediatric Formulation

## Key facts

- **NCT ID:** NCT00831675
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831675, "Study of Safety and Immunogenicity of Fluzone® in Healthy Children". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00831675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*